SciELO - Scientific Electronic Library Online

 
vol.57 issue1Elementos esenciales y no esenciales en el hígado humano: un aporte para establecer valores de referencia de la región noroeste de la ArgentinaImplicancias fisiopatológicas de la hiperhomocisteinemia author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

Share


Acta bioquímica clínica latinoamericana

Print version ISSN 0325-2957On-line version ISSN 1851-6114

Abstract

ZENI CORONEL, Estefanía Magalí; BONANNO, Marina Soledad; SEIJO, Mariana  and  ZENI, Susana Noemí. MicroARN circulantes y su potencialidad como futuros biomarcadores óseos. Acta bioquím. clín. latinoam. [online]. 2023, vol.57, n.1, pp.25-33. ISSN 0325-2957.

Osteoblasts and osteoclasts activity determines the level of the bone remodelling process which can be assessed by biochemical markers of bone formation and resorption. However, bone marker levels are subject to a series of variables resand, furthermore, they lack or have little prognostic values. MicroRNAs (miRNAs) were recently studied as a potential alternative to be used as new bone biomarkers. The miRNAs are endogenous small noncoding RNA molecules (15–25 nucleotides) that regulate many biological functions by inhibiting or degrading specific messenger RNAs. Bone-specific miRNAs exert regulatory functions on key transcriptional factors involved in osteoblastogenesis and osteoclastogenesis, modifying the bone remodelling process. Most miRNAs remain within the cell, but some of them are released into circulation. Circulating miRNAs show great stability in biological fluids, which makes them excellent candidates to be used as new bone biomarkers. Modifications in the normal pattern of bone-specific circulating miRNA might reflect changes in bone metabolism, signalling the possible onset or progression of bone diseases, such as osteoporosis. Although promising, the use of specific circulating miRNAs as new bone biomarkers in clinical practice implies fulfilling a series of requirements that lead to standardising the pre-analytical, analytical and post-analytical conditions of these molecules. The present review gives an overview on the clinical studies related to the possible use of specific circulating miRNAs as new bone biomarkers.

Keywords : Bone remodelling; Osteoporosis; MicroRNAs.

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )